TransMedics GroupTMDX

那斯達克 · USD
120.55
+1.58
(+1.33%)
收盤 08/02 03:59 (UTC+8)
盤後 
121.20 
+0.65 
(+0.54%)
08/02 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.31
  • 0.42
  • 0.52
  • 0.66
  • 0.81
  • 0.97
  • 1.14
  • 1.09
  • 1.22
  • 1.44
icon
  • 22.16
  • 32.44
  • 26.26
  • 26.62
  • 22.19
  • 19.31
  • 18.02
  • -4.85
  • 11.83
  • 18.02
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
143,537
121,624
108,761
114,305
96,850
81,174
66,430
52,465
41,554
31,375
營業成本
55,30949,61147,91645,04436,88833,25025,76815,72412,78810,672
營業毛利
88,228
72,013
60,845
69,261
59,962
47,924
40,662
36,741
28,766
20,703
營業費用
60,78563,36956,92256,753-45,32168,99737,64730,85527,482
研發費用
17,16016,46414,26613,85811,38010,76111,1328,2915,8715,756
推銷及管理費用
43,62546,90542,65642,89536,16134,56030,65329,35624,98421,726
非經常性項目費用
------27,212---
其他營業費用
----------
營業利益
27,443
8,644
3,923
12,508
12,421
2,603
-28,335
-906
-2,089
-6,779
其他收入及費用
2,6941,9163,9393,2683,5704,8654,9962,4315551,085
利息費用
3,4613,5713,6173,6233,5983,6053,5902,5051,0911,007
稅前純益
26,676
6,989
4,245
12,153
12,393
3,863
-26,929
-980
-2,625
-6,701
所得稅
99413229-41196-168-1,507211119
稅後純益
25,682
6,857
4,216
12,194
12,197
4,031
-25,422
-1,001
-2,636
-6,720
基本每股稅後盈餘(元)
0.760.200.130.370.370.12-0.78-0.03-0.08-0.21
稀釋每股稅後盈餘(元)
0.700.200.110.350.350.12-0.78-0.03-0.08-0.20
基本平均股數(千股)
33721.0033592.0033441.0033119.0032760.0032644.0032614.0032545.0032260.0032010.00
稀釋平均股數(千股)
39914.0035211.0035683.0035288.0034678.0034179.0032614.0032545.0032260.0032010.00
還原基本每股稅後盈餘(元)
0.760.200.130.370.370.12-0.78-0.03-0.08-0.21
還原稀釋每股稅後盈餘(元)
0.700.200.110.350.350.12-0.78-0.03-0.08-0.20
還原基本平均股數(千股)
33,72133,59233,44133,11932,76032,64432,61432,54532,26032,010
還原稀釋平均股數(千股)
39,91435,21135,68335,28834,67834,17932,61432,54532,26032,010
EBITDA(千元)
36,27416,24013,03920,37520,29311,073-21,4462,917-247-4,409

大家都在看

HOT